Bezafibrate reduces blood glucose in type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 49, Issue 3, 2000, Pages 331-334

  Ogawa, Susumu ^a,b   Takeuchi, Kazuhisa ^a,b   Sugimura, Kazuhiko ^a,b   Fukuda, Motoshi ^a,b   Lee, Ribun ^a,b   Ito, Sadayoshi ^a,b   Sato, Tokutaro ^a,b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034064204     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)90176-8     Document Type: Article

References (20)

1. Kostner GM, Schernthaner G: Apolipoproteins in diabetes mellitus, in Monographs of Atherosclerosis, vol 13. Basel, Switzerland, Karger Basel, 1985, pp 12-24
2. Haffner SM, Valdez RA, Hazuda HP, et al: Prospective analysis of the insulin-resistance (syndrome X). Diabetes 41:715-722, 1992
3. Shigenori F, Matuzawa Y, Tokunaga K, et al: Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36:54-59, 1987
4. DeFronzo RA, Ferrannini E: Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
5. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: A key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
6. Liu LS, Spelleken M, Rerig K, et al: Tumor necrosis factor α acutely inhibits insulin signaling in human adipocytes. Diabetes 47:515-522, 1998
7. Wennlund LF, Amer P: Relationship between circulating leptin and peripheral fat distribution in obese subjects. Int J Obes Relat Metab Disord 21:255-269, 1997
8. Cohen B, Novick D, Rubinstein M: Modulation of insulin activity by leptin. Science 274:1185-1188, 1996
9. Kroder G, Bossenmaier B, Kellerer M, et al: Tumor necrosis factor-α and hyperglycemia-induced insulin resistance: Evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 97:1471-1477, 1996
10. Schoonjans K, Staels B, Auwerx J: The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109, 1996
11. Inoue I, Noji S, Shen M, et al: The peroxisome proliferator-activated receptor α (PPAR-α) regulates the plasma thiobarbituric acid-reactive substance (TBARS) levels. Biochem Biophys Res Commun 237:606-610, 1997
12. Spiegelman BM: PPAR-γ: Adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514, 1998
13. Nolan JJ, Olefsky JM, Nyce MR, et al: Effects of troglitazone on leptin production. Diabetes 45:1276-1278, 1996
14. Kobayashi M, Shigeta Y, Hirata Y, et al: Improvement of glucose tolerance in NIDDM by clofibrate: Randomized double-blind study. Diabetes Care 11:495-499, 1988
15. Jones IR, Swai A, Taylor R, et al: Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM. Diabetes Care 13:855-863, 1990
16. Kosykh VA, Podrez EA, Novikov DK, et al: Effect of bezafibrate on lipoprotein secretion by cultured human hepatocytes. Atherosclerosis 68:67-76, 1987
17. Staels B, Dallongeville J, Auwerx J, et al: Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98:2088-2093, 1998
18. Ferrannini E, Barrett EJ, Bevilacqua S, et al: Effects of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747, 1983
19. Golay A, Swislocki ALM, Chen Y-D, et al: Relationship between plasma free fatty acid concentration, endogenous glucose production and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism 36:692-696, 1987
20. Masuzaki H, Ogawa Y, Isse N, et al: Human obese gene expression: Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44:855-858, 1995